Reduced IFN- γ levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in Bangladeshi patients

The coronavirus disease 2019 (COVID-19) pandemic, engendered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a global disaster since its outbreak in Wuhan, China, in December 2019 [1]. As of March 2022, there were over 507 million confirmed COVID-19 cases and a death toll of more than 62 million, with the case fatality rate ranging from 0.04% to 18.18% reported worldwide; however, Bangladesh experienced approximately 2 million cases and total deaths of less than 30,000 [2].

Source: Experimental Hematology - November 26, 2022 Category: Hematology Authors: Mohammed Moinul Islam, Shafiqul Islam, Ridwan Ahmed, Mohit Majumder, Bishu Sarkar, Md. Ejajur Rahman Himu, Md Kawser, Alamgir Hossain, Mohammad Jewel Mia, Rashed Rezwan Parag, Md. Rakibul Hassan Bulbul, Shakeel Ahmed, M.A. Sattar, Rajdeep Biswas, Moumita Tags: Research Article Source Type: research